- Home
- GLP vs RCKT Comparison
GLP vs RCKT Comparison
Compare GLP & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLP
- RCKT
- Stock Information
- Founded
- GLP 2005
- RCKT 1999
- Country
- GLP United States
- RCKT United States
- Employees
- GLP 5060
- RCKT N/A
- Industry
- GLP Oil Refining/Marketing
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- GLP Energy
- RCKT Health Care
- Exchange
- GLP Nasdaq
- RCKT Nasdaq
- Market Cap
- GLP 1.7B
- RCKT 1.4B
- IPO Year
- GLP 2005
- RCKT N/A
- Fundamental
- Price
- GLP $49.79
- RCKT $13.98
- Analyst Decision
- GLP Strong Buy
- RCKT Strong Buy
- Analyst Count
- GLP 1
- RCKT 9
- Target Price
- GLP $54.00
- RCKT $53.22
- AVG Volume (30 Days)
- GLP 76.0K
- RCKT 744.0K
- Earning Date
- GLP 11-08-2024
- RCKT 11-07-2024
- Dividend Yield
- GLP 5.90%
- RCKT N/A
- EPS Growth
- GLP N/A
- RCKT N/A
- EPS
- GLP 3.26
- RCKT N/A
- Revenue
- GLP $17,386,440,000.00
- RCKT N/A
- Revenue This Year
- GLP $26.21
- RCKT N/A
- Revenue Next Year
- GLP $22.37
- RCKT $411.05
- P/E Ratio
- GLP $15.19
- RCKT N/A
- Revenue Growth
- GLP 5.31
- RCKT N/A
- 52 Week Low
- GLP $33.20
- RCKT $13.80
- 52 Week High
- GLP $50.85
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- GLP 64.02
- RCKT 27.71
- Support Level
- GLP $48.20
- RCKT $16.65
- Resistance Level
- GLP $49.85
- RCKT $17.83
- Average True Range (ATR)
- GLP 1.13
- RCKT 0.89
- MACD
- GLP 0.17
- RCKT -0.27
- Stochastic Oscillator
- GLP 96.57
- RCKT 4.12
About GLP Global Partners LP Common Units representing Limited Partner Interests
Global Partners LP is an U.S.-based limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.